The Role of Vitamin B6 in Reducing Serum Prolactin in Comparison to Cabergoline
International Journal of Pharmaceutical Quality Assurance · 2019
DOI: 10.25258/ijpqa.10.1.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, 2019. Verfasst von Suha J. Witwit. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Hyperprolactinemia is a common endocrine disorder of hypothalamic-pituitary axis. It affect about 4-17% of women in reproductive age and about 3-10% of patients with polycystic ovaries. Vitamin B6 is an effective prolactin inhibitor that is extremely cheap and safe.it exerts hypothalamic dopaminergic effect which causes a significant reduction in prolactin level. The aim of the study is To evaluate the effectiveness of vitamin B6 in reducing serum prolactin in Hyperprolactinemic patient. Compare this effect to that of cabergoline.
Zitieren
APA
Witwit, S. J. (2019). The Role of Vitamin B6 in Reducing Serum Prolactin in Comparison to Cabergoline. International Journal of Pharmaceutical Quality Assurance. https://doi.org/10.25258/ijpqa.10.1.17
Vancouver
Witwit SJ. The Role of Vitamin B6 in Reducing Serum Prolactin in Comparison to Cabergoline. International Journal of Pharmaceutical Quality Assurance. 2019. doi:10.25258/ijpqa.10.1.17
BibTeX
@article{Witwit2019,
author = {Witwit, Suha J.},
title = {The Role of Vitamin B6 in Reducing Serum Prolactin in Comparison to Cabergoline},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2019},
doi = {10.25258/ijpqa.10.1.17}
}
EUVIMED